GIP and GLP-1 receptor co-agonist

Ct868 sc

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

CT868_SC

Mechanism: Dual incretin agonist (tirzepatide and others)
Trials: 0
Participants in these arms: 0

Doses in this pooled treatment

Ct868 sc 1p75mg qd
Ct868 sc 4p0mg qd

Ct868 sc

Doses in this pooled treatment

Trials